These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 10798222)

  • 1. Lycopene interferes with cell cycle progression and insulin-like growth factor I signaling in mammary cancer cells.
    Karas M; Amir H; Fishman D; Danilenko M; Segal S; Nahum A; Koifmann A; Giat Y; Levy J; Sharoni Y
    Nutr Cancer; 2000; 36(1):101-11. PubMed ID: 10798222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lycopene is a more potent inhibitor of human cancer cell proliferation than either alpha-carotene or beta-carotene.
    Levy J; Bosin E; Feldman B; Giat Y; Miinster A; Danilenko M; Sharoni Y
    Nutr Cancer; 1995; 24(3):257-66. PubMed ID: 8610045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proinflammatory cytokines block growth of breast cancer cells by impairing signals from a growth factor receptor.
    Shen WH; Zhou JH; Broussard SR; Freund GG; Dantzer R; Kelley KW
    Cancer Res; 2002 Aug; 62(16):4746-56. PubMed ID: 12183434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lycopene inhibition of IGF-induced cancer cell growth depends on the level of cyclin D1.
    Nahum A; Zeller L; Danilenko M; Prall OW; Watts CK; Sutherland RL; Levy J; Sharoni Y
    Eur J Nutr; 2006 Aug; 45(5):275-82. PubMed ID: 16565789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lycopene supplementation inhibits lung squamous metaplasia and induces apoptosis via up-regulating insulin-like growth factor-binding protein 3 in cigarette smoke-exposed ferrets.
    Liu C; Lian F; Smith DE; Russell RM; Wang XD
    Cancer Res; 2003 Jun; 63(12):3138-44. PubMed ID: 12810641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lycopene induces cell growth inhibition by altering mevalonate pathway and Ras signaling in cancer cell lines.
    Palozza P; Colangelo M; Simone R; Catalano A; Boninsegna A; Lanza P; Monego G; Ranelletti FO
    Carcinogenesis; 2010 Oct; 31(10):1813-21. PubMed ID: 20699249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
    Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
    Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lycopene: modes of action to promote prostate health.
    Wertz K; Siler U; Goralczyk R
    Arch Biochem Biophys; 2004 Oct; 430(1):127-34. PubMed ID: 15325920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lycopene and other carotenoids inhibit estrogenic activity of 17beta-estradiol and genistein in cancer cells.
    Hirsch K; Atzmon A; Danilenko M; Levy J; Sharoni Y
    Breast Cancer Res Treat; 2007 Aug; 104(2):221-30. PubMed ID: 17051425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo.
    Burtrum D; Zhu Z; Lu D; Anderson DM; Prewett M; Pereira DS; Bassi R; Abdullah R; Hooper AT; Koo H; Jimenez X; Johnson D; Apblett R; Kussie P; Bohlen P; Witte L; Hicklin DJ; Ludwig DL
    Cancer Res; 2003 Dec; 63(24):8912-21. PubMed ID: 14695208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of lycopene on the insulin-like growth factor (IGF) system in premenopausal breast cancer survivors and women at high familial breast cancer risk.
    Voskuil DW; Vrieling A; Korse CM; Beijnen JH; Bonfrer JM; van Doorn J; Kaas R; Oldenburg HS; Russell NS; Rutgers EJ; Verhoef S; van Leeuwen FE; van't Veer LJ; Rookus MA
    Nutr Cancer; 2008; 60(3):342-53. PubMed ID: 18444168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lycopene and 1,25-dihydroxyvitamin D3 cooperate in the inhibition of cell cycle progression and induction of differentiation in HL-60 leukemic cells.
    Amir H; Karas M; Giat J; Danilenko M; Levy R; Yermiahu T; Levy J; Sharoni Y
    Nutr Cancer; 1999; 33(1):105-12. PubMed ID: 10227052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal growth factor induces insulin receptor substrate-2 in breast cancer cells via c-Jun NH(2)-terminal kinase/activator protein-1 signaling to regulate cell migration.
    Cui X; Kim HJ; Kuiatse I; Kim H; Brown PH; Lee AV
    Cancer Res; 2006 May; 66(10):5304-13. PubMed ID: 16707456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of acyclo-retinoic acid and lycopene on activation of the retinoic acid receptor and proliferation of mammary cancer cells.
    Ben-Dor A; Nahum A; Danilenko M; Giat Y; Stahl W; Martin HD; Emmerich T; Noy N; Levy J; Sharoni Y
    Arch Biochem Biophys; 2001 Jul; 391(2):295-302. PubMed ID: 11437362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Castration-induced up-regulation of insulin-like growth factor binding protein-5 potentiates insulin-like growth factor-I activity and accelerates progression to androgen independence in prostate cancer models.
    Miyake H; Pollak M; Gleave ME
    Cancer Res; 2000 Jun; 60(11):3058-64. PubMed ID: 10850457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor and epidermal growth factor independence in human mammary carcinoma cells with c-erbB-2 gene amplification and progressively elevated levels of tyrosine-phosphorylated p185erbB-2.
    Ram TG; Dilts CA; Dziubinski ML; Pierce LJ; Ethier SP
    Mol Carcinog; 1996 Mar; 15(3):227-38. PubMed ID: 8597535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Luteolin inhibits insulin-like growth factor 1 receptor signaling in prostate cancer cells.
    Fang J; Zhou Q; Shi XL; Jiang BH
    Carcinogenesis; 2007 Mar; 28(3):713-23. PubMed ID: 17065200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lycopene effects contributing to prostate health.
    Wertz K
    Nutr Cancer; 2009; 61(6):775-83. PubMed ID: 20155615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant insulin-like growth factor binding protein-1 inhibits IGF-I, serum, and estrogen-dependent growth of MCF-7 human breast cancer cells.
    Figueroa JA; Sharma J; Jackson JG; McDermott MJ; Hilsenbeck SG; Yee D
    J Cell Physiol; 1993 Nov; 157(2):229-36. PubMed ID: 7693722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re-expression of estrogen receptor alpha in estrogen receptor alpha-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth.
    Oesterreich S; Zhang P; Guler RL; Sun X; Curran EM; Welshons WV; Osborne CK; Lee AV
    Cancer Res; 2001 Aug; 61(15):5771-7. PubMed ID: 11479214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.